Losers
- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) shares dipped 58.9% to close at $5.85 on Tuesday after the company announced it terminated the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary angioedema.
- Oblong, Inc (NASDAQ: OBLG) fell 40.3% to close at $0.2390 after jumping 167% on Monday.
- FaZe Holdings Inc. (NASDAQ: FAZE) fell 39.1% to close at $4.96 after the company issued a filing showing issuance of up to roughly 5.92 million shares of common stock, the resale of up to roughly 64 million shares of common stock and the resale of roughly 173,000 warrants.
- FedNat Holding Company (NASDAQ: FNHC) shares fell 37% to close at $0.2963 after surging around 309% on Monday.
- Verastem, Inc. (NASDAQ: VSTM) dropped 34.6% to close at $0.5718 after the company announced RAMP VS-6766 clinical trials and corporate updates.
- Rallybio Corporation (NASDAQ: RLYB) dropped 27.6% to close at $10.76. Rallybio recently announced preliminary results from its ongoing Phase 1b proof-of-concept study of RLYB212 to prevent fetal and neonatal alloimmune thrombocytopenia.
- Atlis Motor Vehicles, Inc. (NASDAQ: AMV) fell 22.6% to close at $14.30 after declining over 9% on Monday.
- AXT, Inc. (NASDAQ: AXTI) fell 21.1% to close at $5.53 after the company cut preliminary Q3 revenue guidance below estimates.
- Cryo-Cell International, Inc. (NYSE: CCEL) dipped 18.5% to settle at $5.30.
- Wearable Devices Ltd. (NASDAQ: WLDS) dipped 17.6% to close at $1.08.
- COMSovereign Holding Corp. (NASDAQ: COMS) dropped 17.3% to settle at $0.0630.
- Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) declined 17% to close at $0.3303.
- Mondee Holdings, Inc. (NASDAQ: MOND) fell 15.4% to close at $7.44.
- Connect Biopharma Holdings Limited (NASDAQ: CNTB) dropped 15.3% to close at $1.11. Connect Biopharma announced topline results for the primary analysis population of the pivotal trial of CBP-201, in patients with moderate-to-severe atopic dermatitis (AD) in China.
- Athersys, Inc. (NASDAQ: ATHX) declined 13.7% to close at $1.89.
- Cocrystal Pharma, Inc. (NASDAQ: COCP) fell 13.7% to settle at $0.2587 after the company announced a 1-for-12 reverse stock split.
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) declined 12.9% to close at $21.59. Maravai LifeSciences announced CEO leadership transition.
- Montauk Renewables, Inc. (NASDAQ: MNTK) declined 11.9% to close at $15.89.
- Lottery.com Inc. (NASDAQ: LTRY) fell 11.7% to close at $0.2661 after jumping 34% on Monday.
- Quanergy Systems, Inc. (NASDAQ: QNGY) fell 10.5% to close at $0.1885. Quanergy announced a 1-for-20 reverse stock split.
- MMTec, Inc. (NASDAQ: MTC) dropped 10.3% to close at $1.39.
- FLJ Group Limited (NASDAQ: FLJ) dropped 9.9% to close at $1.73.
- Theratechnologies Inc. (NASDAQ: THTX) shares fell 5.2% to close at $2.18. Theratechnologies announced FDA approval of Trogarzo for administration by IV push.
- Sportradar Group AG (NASDAQ: SRAD) dropped 5.1% to close at $8.31 after B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from $14 to $8.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.